Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2021-06-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
关于全资子公司存续分立的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the internal restructuring of a wholly-owned subsidiary through a division (存续分立). It details the board meeting resolution, the division plan, changes in registered capital and equity structure, asset and liability allocation, and the impact and risks of the division. There are no financial statements or comprehensive financial performance data presented, nor is this a report or presentation. The document is a formal corporate announcement about a corporate action approved by the board, not requiring shareholder approval, and it does not fit into categories like Annual Report, Interim Report, or Capital/Financing Update. It is not a regulatory filing of a financial report but a corporate restructuring announcement. The best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other categories.
2021-06-21 Chinese
独立董事关于第五届董事会第九次（临时）会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding the pre-approval of matters related to a specific board meeting of Yingkang Life Technology Co., Ltd. It discusses approval of daily related-party transactions for 2021 and a draft revision of a major asset purchase and related-party transaction report. The content focuses on governance and board-level approvals rather than financial results, earnings, or regulatory filings. It is not an annual or interim report, audit report, or earnings release. It is not a proxy solicitation or voting results announcement. The document is a board/management related opinion on corporate transactions and governance matters, specifically related to board meeting agenda items and approvals. Therefore, the best fitting category is Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS. Confidence is high given the clear focus on board opinions and approvals.
2021-06-21 Chinese
第五届董事会第九次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the company's fifth board of directors' ninth (extraordinary) meeting. It details the meeting's attendance, the approval of various proposals including stock option cancellations, subsidiary restructuring, related party transactions, and a major asset purchase report. The document includes voting results and mentions that some proposals will be submitted to the shareholders' meeting later. The content focuses on board decisions and management-level approvals rather than financial results or detailed reports. The document length is about 3208 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report. There is no detailed financial data or comprehensive report content. Therefore, this document fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management.
2021-06-21 Chinese
第五届监事会第九次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 盈康生命科技股份有限公司 regarding several corporate governance matters, including stock option cancellations, related party transactions, and approval of a major asset purchase report draft. It includes voting results and procedural compliance statements. The document is not a full financial report, audit report, or earnings release, nor is it a shareholder meeting presentation or voting result declaration. It is a formal announcement of board-level decisions and approvals, which fits best under Board/Management Information (MANG). The document length is short (1958 characters), and it contains detailed meeting resolutions rather than just an announcement of a report publication or a regulatory filing. Therefore, the classification is MANG with high confidence.
2021-06-21 Chinese
北京市金杜律师事务所关于公司重大资产购买暨关联交易之内幕信息知情人股票交易自查情况的专项核查意见
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion issued by a law firm (北京市金杜律师事务所) regarding a special investigation on insider trading self-check related to a major asset purchase and related party transaction by 盈康生命科技股份有限公司. It includes detailed information about the investigation period, scope, stock trading activities of insiders, and conclusions about compliance with securities laws. The document is not a financial report, earnings release, or management discussion. It is a legal proceeding-related report focusing on insider trading and compliance verification. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length (6365 characters) and content confirm it is a full report, not just an announcement or certification.
2021-06-08 Chinese
国泰君安证券股份有限公司关于公司本次交易相关内幕信息知情人买卖股票自查情况的自查报告之独立财务顾问核查意见
Audit Report / Information Classification · 95% confidence The document is a self-inspection report by an independent financial advisor regarding insider trading related to a major asset acquisition transaction by Yingkang Life Technology Co., Ltd. It includes detailed investigation and statements about stock trading activities by insiders and related parties during the transaction period. The document references regulatory guidelines on major asset restructuring and insider trading, and provides an opinion on compliance and the absence of insider trading. It is not a financial report, earnings release, or general announcement but a specialized audit or compliance report related to the transaction. Therefore, it fits best under the category of Audit Report / Information (AR). The document length and content confirm it is a full report, not just an announcement or certification. FY 2021
2021-06-08 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.